Ensifentrine (RPL554): an inhaled "bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease / Cazzola, M; Page, C; Calzetta, L; Matera, Mg. - In: PHARMACEUTICAL PATENT ANALYST. - ISSN 2046-8954. - 7:6(2018), pp. 249-257. [10.4155/ppa-2018-0030]

Ensifentrine (RPL554): an inhaled "bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease

Calzetta L;
2018

Ensifentrine (RPL554): an inhaled "bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease / Cazzola, M; Page, C; Calzetta, L; Matera, Mg. - In: PHARMACEUTICAL PATENT ANALYST. - ISSN 2046-8954. - 7:6(2018), pp. 249-257. [10.4155/ppa-2018-0030]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2878071
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact